PubRank

Richard J Wong

Author PubWeight™ 70.66‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS). Thyroid 2014 2.04
2 Correlation of osteoradionecrosis and dental events with dosimetric parameters in intensity-modulated radiation therapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2011 1.80
3 Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: an update of the Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys 2010 1.77
4 Endoscopic retrograde dilation of completely occlusive esophageal strictures. Ann Thorac Surg 2006 1.71
5 Nectin-1 expression by squamous cell carcinoma is a predictor of herpes oncolytic sensitivity. Mol Ther 2007 1.71
6 Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-kettering Cancer Center experience. Int J Radiat Oncol Biol Phys 2009 1.58
7 Treatment of anaplastic thyroid carcinoma in vitro with a mutant vaccinia virus. Surgery 2007 1.54
8 18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI. J Nucl Med 2006 1.46
9 Sentinel lymph node biopsy accurately stages the regional lymph nodes for T1-T2 oral squamous cell carcinomas: results of a prospective multi-institutional trial. J Clin Oncol 2010 1.40
10 Paracrine regulation of pancreatic cancer cell invasion by peripheral nerves. J Natl Cancer Inst 2010 1.36
11 Oncolytic vaccinia virotherapy of anaplastic thyroid cancer in vivo. J Clin Endocrinol Metab 2008 1.35
12 Oral tongue cancer gene expression profiling: Identification of novel potential prognosticators by oligonucleotide microarray analysis. BMC Cancer 2009 1.30
13 Intensity-modulated radiotherapy in postoperative treatment of oral cavity cancers. Int J Radiat Oncol Biol Phys 2008 1.27
14 Results of surgical salvage after failure of definitive radiation therapy for early-stage squamous cell carcinoma of the glottic larynx. Arch Otolaryngol Head Neck Surg 2006 1.25
15 NCCN task force: clinical utility of PET in a variety of tumor types. J Natl Compr Canc Netw 2009 1.24
16 AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: THE INCREASING INCIDENCE OF THYROID CANCER. Endocr Pract 2015 1.22
17 Lymph node density is a significant predictor of outcome in patients with oral cancer. Cancer 2009 1.20
18 Oncolytic vaccinia therapy of squamous cell carcinoma. Mol Cancer 2009 1.17
19 Intensity-modulated radiation therapy in oropharyngeal carcinoma: effect of tumor volume on clinical outcomes. Int J Radiat Oncol Biol Phys 2011 1.17
20 The role of novel oncogenes squamous cell carcinoma-related oncogene and phosphatidylinositol 3-kinase p110alpha in squamous cell carcinoma of the oral tongue. Clin Cancer Res 2003 1.11
21 Fine-needle aspiration biopsy of salivary gland lesions in a selected patient population. Arch Otolaryngol Head Neck Surg 2004 1.08
22 Second primary malignancy of the aerodigestive tract in patients treated for cancer of the oral cavity and larynx. Head Neck 2005 1.05
23 Invasive thyroid cancer: management of the trachea and esophagus. Otolaryngol Clin North Am 2008 1.01
24 Prognostic implication of sentinel lymph node biopsy in cutaneous head and neck melanoma. Head Neck 2010 1.00
25 Long-term regional control in the observed neck following definitive chemoradiation for node-positive oropharyngeal squamous cell cancer. Int J Cancer 2013 0.96
26 Nectin-1 is a marker of thyroid cancer sensitivity to herpes oncolytic therapy. J Clin Endocrinol Metab 2007 0.95
27 Radiation impairs perineural invasion by modulating the nerve microenvironment. PLoS One 2012 0.94
28 Predictors of outcome for advanced-stage supraglottic laryngeal cancer. Head Neck 2009 0.94
29 Endoneurial macrophages induce perineural invasion of pancreatic cancer cells by secretion of GDNF and activation of RET tyrosine kinase receptor. Cancer Res 2012 0.93
30 Target volume delineation in oropharyngeal cancer: impact of PET, MRI, and physical examination. Int J Radiat Oncol Biol Phys 2011 0.93
31 Enhanced nectin-1 expression and herpes oncolytic sensitivity in highly migratory and invasive carcinoma. Clin Cancer Res 2005 0.93
32 Treatment of aggressive thyroid cancer with an oncolytic herpes virus. Int J Cancer 2004 0.93
33 Nerve-sparing therapy with oncolytic herpes virus for cancers with neural invasion. Clin Cancer Res 2007 0.92
34 Radiotherapy after surgical resection for head and neck mucosal melanoma. Am J Clin Oncol 2010 0.92
35 Effective oncolytic vaccinia therapy for human sarcomas. J Surg Res 2011 0.92
36 Radiation therapy potentiates effective oncolytic viral therapy in the treatment of lung cancer. Ann Thorac Surg 2005 0.92
37 Synergy of a herpes oncolytic virus and paclitaxel for anaplastic thyroid cancer. Clin Cancer Res 2008 0.91
38 Real-time diagnostic imaging of tumors and metastases by use of a replication-competent herpes vector to facilitate minimally invasive oncological surgery. FASEB J 2006 0.90
39 Clinical nodal stage is an independently significant predictor of distant failure in patients with squamous cell carcinoma of the larynx. Ann Surg 2003 0.90
40 Utility of a PI3K/mTOR inhibitor (NVP-BEZ235) for thyroid cancer therapy. PLoS One 2012 0.90
41 Correlation of a priori DCE-MRI and (1)H-MRS data with molecular markers in neck nodal metastases: Initial analysis. Oral Oncol 2012 0.90
42 Real-time intraoperative detection of breast cancer axillary lymph node metastases using a green fluorescent protein-expressing herpes virus. Ann Surg 2006 0.89
43 Clinical and pathologic prognostic features in acinic cell carcinoma of the parotid gland. Cancer 2009 0.89
44 Selective neck dissection in node-positive squamous cell carcinoma of the head and neck. Otolaryngol Head Neck Surg 2012 0.89
45 Nomograms for preoperative prediction of prognosis in patients with oral cavity squamous cell carcinoma. Cancer 2013 0.88
46 Therapeutic effects of a fusogenic newcastle disease virus in treating head and neck cancer. Head Neck 2010 0.88
47 Combination of mutated herpes simplex virus type 1 (G207 virus) with radiation for the treatment of squamous cell carcinoma of the head and neck. Eur J Cancer 2005 0.87
48 Kimura disease: diagnostic challenges and clinical management. Am J Otolaryngol 2011 0.87
49 Imaging of lymph node micrometastases using an oncolytic herpes virus and [F]FEAU PET. PLoS One 2009 0.87
50 Cribriform-morular variant of papillary thyroid carcinoma: an indication to screen for occult FAP. Fam Cancer 2014 0.85
51 High-dose-rate interstitial brachytherapy in recurrent and previously irradiated head and neck cancers--preliminary results. Brachytherapy 2007 0.84
52 Attenuated multimutated herpes simplex virus-1 effectively treats prostate carcinomas with neural invasion while preserving nerve function. FASEB J 2008 0.84
53 External beam radiotherapy with or without concurrent chemotherapy in advanced or recurrent non-anaplastic non-medullary thyroid cancer. J Surg Oncol 2014 0.84
54 Squamous cell carcinoma related oncogene regulates angiogenesis through vascular endothelial growth factor-A. Ann Surg Oncol 2004 0.83
55 Utility of a histone deacetylase inhibitor (PXD101) for thyroid cancer treatment. PLoS One 2013 0.82
56 Sensitivity of squamous cell carcinoma lymph node metastases to herpes oncolytic therapy. Clin Cancer Res 2008 0.82
57 Outcomes of primary and secondary tracheoesophageal puncture: a 16-year retrospective analysis. Ear Nose Throat J 2006 0.82
58 Herpes oncolytic therapy of salivary gland carcinomas. Int J Cancer 2008 0.82
59 A phase 1 study of everolimus + weekly cisplatin + intensity modulated radiation therapy in head-and-neck cancer. Int J Radiat Oncol Biol Phys 2013 0.82
60 Utility of a herpes oncolytic virus for the detection of neural invasion by cancer. Neoplasia 2008 0.81
61 The current status of positron-emission tomography scanning in the evaluation and follow-up of patients with head and neck cancer. Curr Opin Otolaryngol Head Neck Surg 2006 0.80
62 AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: POSTOPERATIVE HYPOPARATHYROIDISM - DEFINITIONS AND MANAGEMENT. Endocr Pract 2015 0.79
63 Oncolytic vaccinia virus therapy of salivary gland carcinoma. JAMA Otolaryngol Head Neck Surg 2013 0.78
64 Schwann cells induce cancer cell dispersion and invasion. J Clin Invest 2016 0.78
65 Combination of pet imaging with viral vectors for identification of cancer metastases. Adv Drug Deliv Rev 2011 0.77
66 Oncolysis using herpes simplex virus type 1 engineered to express cytosine deaminase and a fusogenic glycoprotein for head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2010 0.76
67 Aace/Ace disease state clinical review: pancreatic neuroendocrine incidentalomas. Endocr Pract 2015 0.75
68 Intraoperative real-time reflectance confocal microscopy for guiding surgical margins of lentigo maligna melanoma. Dermatol Surg 2015 0.75
69 Epithelial-mesenchymal transition enhances response to oncolytic herpesviral therapy through nectin-1. Hum Gene Ther 2014 0.75
70 Murine model of neuromuscular electrical stimulation on squamous cell carcinoma: potential implications for dysphagia therapy. Head Neck 2011 0.75
71 Positron-emission tomography enhancement after vocal fold injection medialization. Ear Nose Throat J 2017 0.75
72 Successful perioperative use of prothrombin complex concentrate in the treatment of acquired factor X deficiency in the setting of systemic light-chain (AL) amyloidosis. Am J Hematol 2014 0.75
73 AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: TIMING OF MULTIPLE ENDOCRINE NEOPLASIA THYROIDECTOMY AND EXTENT OF CENTRAL NECK LYMPHADENECTOMY. Endocr Pract 2015 0.75
74 Skull base, orbital, and perineural involvement in Waldenström's macroglobulinemia. J Otolaryngol 2006 0.75
75 Functional imaging in head and neck cancer. Curr Oncol Rep 2005 0.75